BOSTON – The Worcester Business Journal reports Boston Scientific is expanding its board of directors.
The medical technology company has added Cathy Smith, Chief Financial Officer of Starbucks, and Christophe Weber, President and CEO of Takeda Pharmaceutical. The additions increase the board from 10 to 12 members.
Smith will serve on the audit, nominating and governance committees, while Weber will serve on executive compensation and human resources as well as risk, science and technology committees.
